Patients at increased risk of developing atrial fibrillation Circulatory System Atrial fibrillation and flutter
Conditions
Interventions
Patients will be randomised 1:1 to either the AliveCor® (intervention) group or the standard care (control) group:
1. Patients in the AliveCor® group use the heart rhythm monitor, an electrocardiogram
Sponsors
ABMU Health Board
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Male or female 65 years+ with one or more of the following risk factors, or 75 years+ with or without these risk factors; 1.1. Hypertension currently treated 1.2. Blood pressure >130/80mmHg not treated 1.3. Any previous stroke or transient ischaemic attack (TIA) 1.4. Diabetes (type 1 or type 2) 1.5. Heart failure 1.6. Ischaemic heart disease 1.7. Peripheral artery disease 2. Local access to the internet
Exclusion criteria
Exclusion criteria: 1. Known atrial fibrillation 2. Currently receiving anticoagulants 3. Known contraindication to anticoagulation (chronic haematology conditions/previous haemorrhagic stroke/ongoing bleeding/liver disease) 4. No access locally to internet 5. Unable to operate the AliveCor® system
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total number of new atrial fibrillation diagnoses within study period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Average time to diagnosis 2. Time to anti-coagulation 3. Patient compliance with monitoring 4. Patient satisfaction with monitoring | — |
Countries
United Kingdom, Wales
Contacts
Public ContactLisa Bastin
Outcome results
None listed